MARIBETH BOBELDYKE: Open Payments
NPI 1396828364 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 65 payments from 18 companies in 2025. Trend: 2023 $580 · 2024 $733 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $295 |
| PFIZER INC. | 11 | $138 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| Novo Nordisk Inc | 4 | $70 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Eisai Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $16 |
Products named: UBRELVY, REXULTI, QULIPTA, PREVNAR 20, NURTEC ODT, Wegovy, VRAYLAR, GEMTESA.
Industry payments across NE — which companies pay providers there.
